These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10374550)

  • 1. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].
    Zhou YB; Leng X; Qi G
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat.
    Braillon A; Lee SS; Girod C; Peignoux-Martinot M; Valla D; Lebrec D
    J Lab Clin Med; 1986 Dec; 108(6):543-8. PubMed ID: 3783027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
    Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide.
    Bernadich C; Bandi JC; Piera C; Bosch J; Rodes J
    Hepatology; 1997 Aug; 26(2):262-7. PubMed ID: 9252132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splanchnic and systemic hemodynamic alterations in chronic, progressive portal hypertensive rats.
    Blanchart A; Garrido MC; Fernández-Muñoz D; Nuño J; Hernando L; López-Novoa JM
    Rev Esp Fisiol; 1984 Dec; 40(4):493-9. PubMed ID: 6397796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of overproduction of plasma prostacyclin in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Jiao Z; Chen Z; Kuang Y
    Chin Med J (Engl); 1998 Dec; 111(12):1064-7. PubMed ID: 11263364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic baroreflex alterations in prehepatic portal hypertensive conscious rats.
    Arranz CT; Balaszczuk AM; Costa MA; Eizayaga FX; Romay S; Mongelli C; Lemberg A
    Arch Physiol Biochem; 1995 Aug; 103(4):422-6. PubMed ID: 8548476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting.
    Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM
    Clin Physiol Biochem; 1990; 8(3):144-52. PubMed ID: 2225722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
    Pérez-Páramo M; Muñoz J; Albillos A; Rossi I; Alvarez-Mon M; Ortiz Berrocal J
    Rev Esp Med Nucl; 1998; 17(4):294-301. PubMed ID: 9721346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
    Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
    Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric mucosal hemodynamics of prehepatic portal hypertensive rat model].
    Zhou Y; Leng X; Qi G
    Zhonghua Yi Xue Za Zhi; 1997 Apr; 77(4):286-9. PubMed ID: 9596931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat.
    Bexis S; McCormick PA; Docherty JR
    Eur J Pharmacol; 2008 Aug; 590(1-3):322-6. PubMed ID: 18603238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship between type of spontaneous portal systemic shunt and portal vein pressure in patients with liver disease.
    Ohnishi K; Nakayama T; Koen H; Saito M; Saito M; Chin N; Terabayashi H; Iida S; Nomura F; Okuda K
    Am J Gastroenterol; 1985 Jul; 80(7):561-4. PubMed ID: 4014107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.
    Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
    Chin Med J (Engl); 2000 Dec; 113(12):1108-11. PubMed ID: 11776147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.